Project Details
Description
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study of AB103 as Compared to Placebo in Patients with Necrotizing Soft Tissue Infections (NSTI)
| Status | Finished |
|---|---|
| Effective start/end date | 7/8/15 → 7/30/20 |
Funding
- ATOXBIO
- U.S. DEPARTMENT OF HEALTH & HUMAN SVCS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.